Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas

被引：583

作者：

Casanueva, Felipe F. ^{[1
]}

Molitch, Mark E.

Schlechte, Janet A.

Abs, Roger

Bonert, Vivien

Bronstein, Marcello D.

Brue, Thierry

Cappabianca, Paolo

Colao, Annamaria

Fahlbusch, Rudolf

Fideleff, Hugo

Hadani, Moshe

Kelly, Paul

Kleinberg, David

Laws, Edward

Marek, Josef

Scanlon, Maurice

Sobrinho, Luis G.

Wass, John A. H.

Giustina, Andrea

机构：

[1] Univ Santiago de Compostela, Dept Med, Div Endocrine, Santiago De Compostela, Spain

[2] Northwestern Univ, Div Endocrinol, Chicago, IL 60611 USA

[3] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA

[4] Univ Ziekenhuis, Dept Endocrinol, Antwerp, Belgium

[5] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA

[6] Univ Sao Paulo, Neuroendocrine Unit, Sao Paulo, Brazil

[7] Univ Mediterranee, Hop Timone, Dept Endocrinol, Marseille, France

[8] Univ Naples Federico II, Dept Neurol Sci, Naples, Italy

[9] Univ Naples Federico II, Dept Endocrinol, Naples, Italy

[10] Univ Erlangen Nurnberg, Dept Neurosurg, Erlangen, Germany

[11] T Alvarez Hosp, Endocrinol Unit, Buenos Aires, DF, Argentina

[12] Tel Aviv Univ, Chaim Sheba Med Ctr, Dept Neurosurg, IL-69978 Tel Aviv, Israel

[13] Hop Necker Enfants Malad, INSERM, U458, Paris, France

[14] NYU, Dept Med, New York, NY 10016 USA

[15] Univ Virginia, Dept Neurosurg, Charlottesville, VA USA

[16] Charles Univ, Dept Med, Prague, Czech Republic

[17] Univ Wales Coll Cardiff, Dept Med, Cardiff CF1 3NS, S Glam, Wales

[18] Portuguese Canc Inst, Dept Endocrinol, Lisbon, Portugal

[19] Churchill Hosp, Dept Endocrinol, Oxford OX3 7LJ, England

[20] Univ Brescia, Dept Internal Med, Brescia, Italy

来源：

CLINICAL ENDOCRINOLOGY | 2006年 / 65卷 / 02期

关键词：

D O I：

10.1111/j.1365-2265.2006.02562.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In June 2005, an ad hoc Expert Committee formed by the Pituitary Society convened during the 9th International Pituitary Congress in San Diego, California. Members of this committee consisted of invited international experts in the field, and included endocrinologists and neurosurgeons with recognized expertise in the management of prolactinomas. Discussions were held that included all interested participants to the Congress and resulted in formulation of these guidelines, which represent the current recommendations on the diagnosis and management of prolactinomas based upon comprehensive analysis and synthesis of all available data.

引用

页码：265 / 273

页数：9

共 52 条

[1] Reproductive toxicity of cabergoline in mice, rats, and rabbits [J].

Beltrame, D ;

Longo, M ;

Mazue, G .

REPRODUCTIVE TOXICOLOGY, 1996, 10 (06) :471-483

[2] DOPAMINE AGONISTS AND PITUITARY-TUMOR SHRINKAGE [J].

BEVAN, JS ;

WEBSTER, J ;

BURKE, CW ;

SCANLON, MF .

ENDOCRINE REVIEWS, 1992, 13 (02) :220-240

[3] FACTORS IN THE OUTCOME OF TRANS-SPHENOIDAL SURGERY FOR PROLACTINOMA AND NONFUNCTIONING PITUITARY-TUMOR, INCLUDING PREOPERATIVE BROMOCRIPTINE THERAPY [J].

BEVAN, JS ;

ADAMS, CBT ;

BURKE, CW ;

MORTON, KE ;

MOLYNEUX, AJ ;

MOORE, RA ;

ESIRI, MM .

CLINICAL ENDOCRINOLOGY, 1987, 26 (05) :541-556

[4]

CASANUEVA FF, 2004, INTERNAL MED TXB, P2018

[5] Long-term treatment with cabergoline, a new long-lasting ergoline derivative, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy [J].

Ciccarelli, E ;

Grottoli, S ;

Razzore, P ;

Gaia, D ;

Bertagna, A ;

Cirillo, S ;

Cammarota, T ;

Camanni, M ;

Camanni, F .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1997, 20 (09) :547-551

[6] Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia [J].

Colao, A ;

Di Sarno, A ;

Cappabianca, P ;

Di Somma, C ;

Pivonello, R ;

Lombardi, G .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21) :2023-2033

[7] Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: A prospective study in 110 patients [J].

Colao, A ;

Di Sarno, A ;

Landi, ML ;

Scavuzzo, F ;

Cappabianca, P ;

Pivonello, R ;

Volpe, R ;

Di Salle, F ;

Cirillo, S ;

Annunziato, L ;

Lombardi, G .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (06) :2247-2252

[8] Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment [J].

Colao, A ;

DiSarno, A ;

Sarnacchiaro, F ;

Ferone, D ;

DiRenzo, G ;

Merola, B ;

Annunziato, L ;

Lombardi, G .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (03) :876-883

[9] Treatment of macroprolactinoma with cabergoline: A study of 85 patients [J].

Ferrari, CI ;

Abs, R ;

Bevan, JS ;

Brabant, G ;

Ciccarelli, E ;

Motta, T ;

Mucci, M ;

Maratori, M ;

Musatti, L ;

Verbessem, G ;

Scanlon, MF .

CLINICAL ENDOCRINOLOGY, 1997, 46 (04) :409-413

[10]

Fideleff HL, 2000, J PEDIATR ENDOCR MET, V13, P261

← 1 2 3 4 5 6 →